UK Consensus on Normal Tissue Dose Constraints for Stereotactic Radiotherapy
- PMID: 29033164
- DOI: 10.1016/j.clon.2017.09.007
UK Consensus on Normal Tissue Dose Constraints for Stereotactic Radiotherapy
Abstract
Six UK studies investigating stereotactic ablative radiotherapy (SABR) are currently open. Many of these involve the treatment of oligometastatic disease at different locations in the body. Members of all the trial management groups collaborated to generate a consensus document on appropriate organ at risk dose constraints. Values from existing but older reviews were updated using data from current studies. It is hoped that this unified approach will facilitate standardised implementation of SABR across the UK and will allow meaningful toxicity comparisons between SABR studies and internationally.
Keywords: Constraints; OAR; SABR; SBRT; normal tissue; stereotactic radiotherapy.
Copyright © 2017 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.
Comment in
-
Normal Tissue Dose Constraints for Multiple Lung Stereotactic Radiotherapy Treatments.Clin Oncol (R Coll Radiol). 2018 Jul;30(7):455. doi: 10.1016/j.clon.2018.03.003. Epub 2018 Mar 21. Clin Oncol (R Coll Radiol). 2018. PMID: 29571935 No abstract available.
-
UK Consensus on Normal Tissue Dose Constraints for Stereotactic Radiotherapy: Reply to Ghafoor et al.Clin Oncol (R Coll Radiol). 2018 Jul;30(7):456. doi: 10.1016/j.clon.2018.03.012. Epub 2018 Apr 11. Clin Oncol (R Coll Radiol). 2018. PMID: 29655554 No abstract available.
MeSH terms
Grants and funding
LinkOut - more resources
Medical